午夜插插,噜噜噜影院,啪啪伊人网,欧美熟夫,景甜吻戏视频,男人强操性感蕾丝美女视频在线网站,日本美女跳舞视频

ChemicalBook Chinese Germany Japanese Korean

上海一飛生物科技有限公司 Company Information
Company Name:    Shanghai Yifei Biotechnology Co. , Ltd.
Tel:    021-65675885
Email:    customer_service@efebio.com
Nationality:    China
WebSite:    http://www.efebio.com
Product List:    11973
93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109 110 111 112 113 114 115 116 117 118 119 120
Product List
Felzartamab 2197112-39-1
CCCI-01 215778-97-5
Zanidatamab 2169946-15-8
Glucocorticoid receptor agonist-1 2166375-82-0
RO7185876 2226038-71-5
Tau-aggregation and neuroinflammation-IN-1 2175953-98-5
MMV688845 2208962-35-8
Sibrotuzumab 216669-97-5
2'-O-(2-Azidoethyl)adenosine 2226475-42-7
Relfovetmab 2171034-70-9
Disitamab 2185868-98-6
Sasanlimab 2206792-50-7
Tinurilimab 2226224-30-0
SHP2-IN-6 hydrochloride 2169223-49-6
MI-389 2222635-92-7
LTβR-IN-1 2189366-77-4
Nidanilimab 2171061-85-9
Cosibelimab 2216751-26-5
Metronidazole-hydroxy-d2 2196180-19-3
AKOS037652256 2171065-77-1
Lacutamab 2187368-16-5
Batoclimab 2187430-05-1
NV-5440 2226614-88-4
Tuberculosis inhibitor 3 2219325-28-5
Benproperine 2156-27-6
Garadacimab 2162134-62-3
Avdoralimab 2226393-85-5
Nurulimab 2168561-20-2
SARS-CoV-2-IN-14 22203-98-1
SOCE inhibitor 1 2169316-15-6
Semorinemab 2159141-27-0
Dovanvetmab 2171034-71-0
Tafolecimab 2225109-03-3
DBCO-PEG3-NHS ester 2163772-16-3
Propionanilide, 3'-hydroxy- 21556-86-5
Astegolimab 2173054-79-8
Befovacimab 2156634-62-5
SCH 57790 221660-80-6
Mitumomab 216503-58-1
Monuron-d6 217488-65-8
Lenalidomide-PEG1-azide 2185795-67-7
Magrolimab 2169232-81-7
Manelimab 2168561-26-8
IRAK4-IN-22 2170694-05-8
Simazine-d5 220621-41-0
Bedinvetmab 2171034-69-6
Encelimab 2173096-82-5
Arg-Gly-Asp-Cys TFA 2171504-22-4
TLR7/8-IN-1 2205095-75-4
Cytembena 21739-91-3
Elsibucol 216167-95-2
TLR7 agonist 1 2178156-33-5
Sonlicromanol hydrochloride 2162149-24-6
KDM2A/7A-IN-1 2169272-46-0
IL-17A antagonist 1 2205034-18-8
L-796,778 217480-25-6
Thalidomide-O-C6-COOH 2169266-69-5
L 756423 216863-66-0
Crobenetine 221019-25-6
Chst15-IN-1 2158198-77-5
K-111 221564-97-2
MY10 2204270-73-3
PSMA I&T 2192281-54-0
Zagociguat 2201048-82-8
INCB-000928 2173389-57-4
(S,R,S)-AHPC-CO-C9-acid 2172819-78-0
AZD8154 2215022-45-8
MY33-3 2204280-41-9
RO0270608 220846-33-3
Visilizumab 219716-33-3
Ruplizumab 220651-94-5
IRAK4-IN-21 2170694-04-7
Nec-34i 2212541-00-7
Zelminemab 2225850-33-7
Axatilimab 2155851-88-8
Amivantamab 2171511-58-1
Pramiconazole 219923-85-0
Labetuzumab 219649-07-7
Pexelizumab 219685-93-5
Petosemtamab 2213450-26-9
Bamocaftor 2204245-48-5
Atinvicitinib 2169273-59-8
PARP10-IN-3 2225800-19-9
(R)-HH2853 2202678-06-4
Mal-amide-PEG8-Val-Ala-PAB-PNP 2210247-59-7
ALDH1A2-IN-1 2204229-64-9
Talquetamab 2226212-40-2
MY33-3 hydrochloride 2204280-42-0
AVG-233 2151937-80-1
Indole-C2-amide-C2-NH2 215789-29-0
4,4-Diphenylbutylamine hydrochloride 22101-90-2
Benzyl-PEG12-alcohol 2218463-17-1
(R)-GSK-3685032 2170140-50-6
ATG7-IN-2 2226227-75-2
Gemnelatinib 2225123-30-6
Navocaftor 2159103-66-7
(S)-Desmethyl-NNC112 221132-62-3
TZ3O 2218754-19-7
(S)-HH2853 2202678-05-3
Ragifilimab 2207590-51-8
93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109 110 111 112 113 114 115 116 117 118 119 120
Copyright 2007©  ChemicalBook. All rights reserved.